Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>News>This Article

Top Pharma and Biotech firms Trust CompacT Automated Cell Culture to Generate their Cell Lines

Published: Friday, January 11, 2013
Last Updated: Friday, January 11, 2013
Bookmark and Share
See the System at SLAS on TAP Biosystems’ Booth #712 to find out why.

TAP Biosystems announced that with its latest installation of CompacT SelecT™, the technology remains the most widely adopted system for automated culture of adherent cell lines in T-flasks, used by major pharmaceutical and biotech companies worldwide. On Booth #712 at the Society for Laboratory Automation and Screening (SLAS) 2013 there is a unique opportunity to see the CompacT SelecT in action.

The CompacT SelecT systems installed in these leading companies offer parallel, aseptic cell culture processing in T75 and T175 flasks at any time of day or night, without scientists having to be present, thus providing a continuous supply of consistent quality cells for use in cell-based screening programmes.

The systems sited have each been tailored with a range of options which allow tasks such as automated cell imaging and analysis, control of culture conditions, media additions and passaging of immortalised, primary cells or stem cells. The cells are being used in applications including high throughput screening, lead optimisation, assay development, target identification and validation, as well as toxicity studies. The stem cell lines are being utilised to support research in therapeutic areas such as oncology and neurology.

The CompacT SelecT system will be on Booth #712 at SLAS2013. To book a demonstration time and find out more about the system options from TAP’s cell culture experts, please contact Matt Walker by email on

Dr Dave Thomas, Product Manager at TAP Biosystems stated: "With the number of automated cell culture technologies increasing, we are pleased that our CompacT SelecT system has become the system of choice in the top pharma and biotech companies. Many of these firms now have multiple systems installed at their North American and European sites and a number are looking to place them in their new Asian drug discovery facilities.”

Thomas added: "The adoption of the CompacT SelecT systems by these leading companies is an excellent endorsement that the technology’s performance capabilities perfectly match their rigorous cell culture demands. Any pharma or biotech scientists looking for a proven and trusted method of consistently generating high quality cell lines should visit us on Booth #712 at SLAS, to discover how a CompacT SelecT system would help them to achieve reproducible results in their cell-based research and development programmes.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Monday, January 20, 2014
Collaboration between TAP Biosystems and UCL to Develop Biomimetic 3D Cancer Models
TAP Biosystems announced new collaboration to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications.
Friday, October 12, 2012
Scientific News
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.
Improving the Efficiency of Red Blood Cell Production
Study points to way of significantly reducing cost of laboratory-produced cells.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos